310 related articles for article (PubMed ID: 19877978)
1. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
4. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM
J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474
[TBL] [Abstract][Full Text] [Related]
5. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
6. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
8. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
Vieta E; Sánchez-Moreno J; Goikolea JM; Colom F; Martínez-Arán A; Benabarre A; Corbella B; Torrent C; Comes M; Reinares M; Brugue E
J Clin Psychopharmacol; 2004 Aug; 24(4):374-8. PubMed ID: 15232327
[TBL] [Abstract][Full Text] [Related]
9. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
Biederman J; Mick E; Hammerness P; Harpold T; Aleardi M; Dougherty M; Wozniak J
Biol Psychiatry; 2005 Oct; 58(7):589-94. PubMed ID: 16239162
[TBL] [Abstract][Full Text] [Related]
10. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
12. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder.
Detke HC; DelBello MP; Landry J; Hoffmann VP; Heinloth A; Dittmann RW
J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):922-934. PubMed ID: 27676420
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
14. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial.
Tramontina S; Zeni CP; Pheula G; Rohde LA
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):129-34. PubMed ID: 17343561
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
[TBL] [Abstract][Full Text] [Related]
16. Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice.
Novick D; Reed C; Haro JM; Gonzalez-Pinto A; Perrin E; Aguado J; Tohen M
Int Clin Psychopharmacol; 2010 Sep; 25(5):257-63. PubMed ID: 20531011
[TBL] [Abstract][Full Text] [Related]
17. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
[TBL] [Abstract][Full Text] [Related]
18. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
Kushner SF; Khan A; Lane R; Olson WH
Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
[TBL] [Abstract][Full Text] [Related]
19. 1-year follow-up of patients treated with risperidone and topiramate for a manic episode.
Vieta E; Goikolea JM; Olivares JM; González-Pinto A; Rodriguez A; Colom F; Comes M; Torrent C; Sánchez-Moreno J
J Clin Psychiatry; 2003 Jul; 64(7):834-9. PubMed ID: 12934986
[TBL] [Abstract][Full Text] [Related]
20. Open-label adjunctive topiramate in the treatment of unstable bipolar disorder.
McIntyre RS; Riccardelli R; Binder C; Kusumakar V
Can J Psychiatry; 2005 Jun; 50(7):415-22. PubMed ID: 16086539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
